Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes
- PMID: 11306523
- DOI: 10.1161/01.cir.103.15.1955
Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes
Abstract
Background: There is accumulating data that acute coronary syndromes relate to recent onset activation of inflammation affecting atherosclerotic plaques. Increased blood levels of oxidized low density lipoprotein (ox-LDL) could play a role in these circumstances.
Methods and results: Ox-LDL levels were measured in 135 patients with acute myocardial infarction (AMI; n=45), unstable angina pectoris (UAP; n=45), and stable angina pectoris (SAP; n=45) and in 46 control subjects using a sandwich ELISA method. In addition, 33 atherectomy specimens obtained from a different cohort of patients with SAP (n=10) and UAP (n=23) were studied immunohistochemically for ox-LDL. In AMI patients, ox-LDL levels were significantly higher than in patients with UAP (P<0.0005) or SAP (P<0.0001) or in controls (P<0.0001) (AMI, 1.95+/-1.42 ng/5 microgram LDL protein; UAP, 1.19+/-0.74 ng/5 microgram LDL protein; SAP, 0.89+/-0.48 ng/5 microgram LDL protein; control, 0.58+/-0.23 ng/5 microgram LDL protein). Serum levels of total, HDL, and LDL cholesterol did not differ among these patient groups. In the atherectomy specimens, the surface area containing ox-LDL-positive macrophages was significantly higher in patients with UAP than in those with SAP (P<0.0001).
Conclusions: This study demonstrates that ox-LDL levels show a significant positive correlation with the severity of acute coronary syndromes and that the more severe lesions also contain a significantly higher percentage of ox-LDL-positive macrophages. These observations suggest that increased levels of ox-LDL relate to plaque instability in human coronary atherosclerotic lesions.
Comment in
-
Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk.Circulation. 2001 Apr 17;103(15):1930-2. doi: 10.1161/01.cir.103.15.1930. Circulation. 2001. PMID: 11306518 No abstract available.
Similar articles
-
The oxidation ratio of LDL: a predictor for coronary artery disease.Dis Markers. 2008;24(6):341-9. doi: 10.1155/2008/371314. Dis Markers. 2008. PMID: 18688083 Free PMC article.
-
Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease.IUBMB Life. 2019 Feb;71(2):277-282. doi: 10.1002/iub.1966. Epub 2018 Nov 10. IUBMB Life. 2019. PMID: 30414358
-
Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases.J Diabetes Complications. 2002 Jan-Feb;16(1):60-4. doi: 10.1016/s1056-8727(01)00210-0. J Diabetes Complications. 2002. PMID: 11872369
-
[Increased apoptosis and necrosis of coronary plaques in unstable angina].Z Kardiol. 1997 Nov;86(11):902-10. doi: 10.1007/s003920050130. Z Kardiol. 1997. PMID: 9480584 Review. German.
-
Oxidized low density lipoprotein, stem cells, and atherosclerosis.Lipids Health Dis. 2012 Jul 2;11:85. doi: 10.1186/1476-511X-11-85. Lipids Health Dis. 2012. PMID: 22747902 Free PMC article. Review.
Cited by
-
Ongoing clinical trials of the pleiotropic effects of statins.Vasc Health Risk Manag. 2005;1(1):29-40. doi: 10.2147/vhrm.1.1.29.58937. Vasc Health Risk Manag. 2005. PMID: 17319096 Free PMC article. Review.
-
Post-Bariatric Hypoglycemia Is Associated with Endothelial Dysfunction and Increased Oxidative Stress.Biomedicines. 2022 Apr 16;10(4):916. doi: 10.3390/biomedicines10040916. Biomedicines. 2022. PMID: 35453666 Free PMC article.
-
Mercury chloride toxicity in human erythrocytes: enhanced generation of ROS and RNS, hemoglobin oxidation, impaired antioxidant power, and inhibition of plasma membrane redox system.Environ Sci Pollut Res Int. 2019 Feb;26(6):5645-5657. doi: 10.1007/s11356-018-04062-5. Epub 2019 Jan 5. Environ Sci Pollut Res Int. 2019. PMID: 30612358
-
Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.Drug Des Devel Ther. 2011;5:283-97. doi: 10.2147/DDDT.S13492. Epub 2011 May 11. Drug Des Devel Ther. 2011. PMID: 21625418 Free PMC article. Review.
-
Immune Complexes and the Risk of CVD in Type 1 Diabetes.Diabetes. 2019 Sep;68(9):1853-1860. doi: 10.2337/db19-0358. Epub 2019 Jun 19. Diabetes. 2019. PMID: 31217176 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous